Comparison of some properties of pronethalol and propranolol

British Journal of Pharmacology

Volumn 120, Issue 4 SUPPL., 1997, Pages 285-299

  Black, J W ^a,b   Duncan, W A M ^a,b   Shanks, R G ^a  

^a AKZO NOBEL CENTRAL RESEARCH   (Netherlands)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ETHANOLAMINE DERIVATIVE; PRONETALOL; PROPRANOLOL;

ANIMAL; ARTICLE; BLOOD PRESSURE; CAT; COMPARATIVE STUDY; DOG; DRUG EFFECT; GUINEA PIG; HALF LIFE TIME; HEART; HISTORY; LD 50; RABBIT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; CATS; DOGS; ETHANOLAMINES; GUINEA PIGS; HALF-LIFE; HEART; HISTORY, 20TH CENTURY; LETHAL DOSE 50; PROPRANOLOL; RABBITS;

EID: 0031063081     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1997.tb06809.x     Document Type: Review

References (46)

1. ABBOUD, F. M., ECKSTEIN, J. W. & ZIMMERMAN, B. G. (1963). Effect of "beta-receptor-blocking drugs" on venous and arterial responses to isoproterenol. Clin. Res., 11, 162.
2. AHLQUIST, R. P. (1948). A study of the adrenotropic receptors. Amer. J. Physiol., 153, 586-600.
3. AHLQUIST, R. P. (1963). Beta adrenergic receptor blockade by naphthylisoproterenol. Fed. Proc., 22, 449.
4. ALCOCK, S. J., BAKER, S. B. DE C. & TUCKER, M. J. (1965). A comparison of the carcinogenicity of pronethalol and propranolol in mice. Brit. med. J., in the press.
5. ALCOCK, S. J. & BOND, P. A. (1964). Observations on the toxicity of Alderlin (pronethalol) in laboratory animals. Proc. Europ. Soc. Stud. Drug Toxicity, 4, 30-39.
6. ALLEYNE, G. A. O., DICKINSON, C. J., DORNHORST, A. C., FULTON, R. M., GREEN, K. G., HILL, I. D., HURST, P., LAURENCE, D. R., PILKINGTON, T., PRICHARD, B. N. C., ROBINSON, B. & ROSENHEIM, M. L. (1963). Effect of pronethalol in angina pectoris. Brit. med. J., ii, 1226-1229.
7. APTHORP, G. H., CHAMBERLAIN, D. A. & HAYWARD, G. W. (1964). The effects of sympathectomy on the electrocardiogram and effort tolerance in angina pectoris. Brit. Heart J., 26, 218-226.
8. BARRETT, A. M. (1965). The effects of some autonomic blocking agents on the heart rates of anaesthetized and pithed rats. Brit. J. Pharmacol., 25, 545-556.
9. BENFEY, B. G. (1962). The effect of phenoxybenzamine on vagal inhibition of the heart. Canad. J. Biochem., 40, 1457-1459.
10. BISHOP, J. M. & SEGEL, N. (1963). The circulatory effects of intravenous pronethalol in man at rest and during exercise in the supine and upright positions. J. Physiol. (Lond.), 169, 112-114P.
11. BLACK, J. W., CROWTHER, A. F., SHANKS, R. G., SMITH, L. H. & DORNHORST, A. C. (1964). A new adrenergic beta-receptor antagonist. Lancet, i, 1080-1081.
12. BLACK, J. W. & STEPHENSON, J. S. (1962). Pharmacology of a new adrenergic beta-receptor-blocking compound (nethalide). Lancet, ii, 311-314.
13. CHAMBERLAIN, D. A. & HOWARD, J. (1964). The haemodynamic effects of β-sympathetic blockade. Brit. Heart J., 26, 213-217.
14. COHEN, J., EFFAT, H., GOODWIN, J. F., OAKLEY, C. M. & STEINER, R. E. (1964). Hypertrophic obstructive cardiomyopathy. Brit. Heart J., 26, 16-32.
15. COTTEN, M. DE V. (1953). Circulatory changes affecting measurement of heart force in situ with strain gauge arches. Amer. J. Physiol., 174, 365-370.
16. DAVIES, M. T. (1959). A universal buffer solution for use in ultra violet spectrophotometry. Analyst, 84 248-251.
17. DONALD, D. E., KVALE, J. & SHEPHERD, J. T. (1964). The effect of an adrenergic beta-receptor antagonist on the cardiovascular system of the dog. J. Pharmacol. exp. Ther., 143, 344-349.
18. DORNHORST, A. C. & LAURENCE, D. R. (1963). Use of pronethalol in phaeochrome tumours. Brit. med. J., ii, 1250-1251.
19. DORNHORST, A. C. & ROBINSON, B. F. (1962). Clinical pharmacology of a beta-adrenergic-blocking agent (nethalide). Lancet, ii, 314-316.
20. DRESEL, P. E. (1960). Blockade of some cardiac actions of adrenaline by dichloroisoproterenol. Canad. J. Biochem., 38, 375-381.
21. EHRINGER, H. & GÖGEL, H. (1963). Zur Wirkung von Nethalide auf eine experimentell ausgelöste Myokardnekrose der Ratte. Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak., 246, 47-48.
22. ERLIJ, D. & MENDEZ, R. (1964). The modification of digitalis intoxication by excluding adrecergic influences on the heart. J. Pharmacol. exp. Ther., 144, 97-103.
23. FURCHGOTT, R. F. (1959). The receptors for epinephrine and norepinephrine. Pharmacol. Rev., 11, 429-442.
24. GRANDJEAN, T. & RIVIER, J.-L. (1963). Utilisation d'un antagoniste des catecholamines (I.C.I. 38,174, "Alderlin") dans le traitement de quelques cas de troubles du rythme cardiaque. Schweiz. med. Wschr., 93, 1101-1104.
25. HARRISON, D. C., BRAUNWALD, E., GLICK, G., MASON, D. T., CHIDSEY, C. A. & ROSS, J. (1964). Effect of beta adrenergic blockade on the circulation with particular reference to observations in patients with hypertrophic subaortic stenosis. Circulation, 19, 84-98.
26. HESS, J. M. & HAMPTOM, L. J. (1964). Prevention of epinephrine-halothane arrhythmias by adrenergic β-receptor blockade. Anesthesiology, 25, 101-102.
27. HOWE, R. (1963). Structure activity relationships of some β-adrenergic blocking agents. Biochem. Pharmacol., 12, suppl. 85.
28. JAMES, T. N. & NADEAU, R. A. (1964). The chronotropic and vagal-blocking actions of naphthylisoproterenol studied by direct perfusion of the sinus node. J. Pharmacol. exp. Ther., 143, 350-355.
29. JOHNSTONE, M. (1964). Beta-adrenergic blockade with pronethalol during anaesthesia. Brit. J. Anaesth., 36, 224-232.
30. KAKO, K., KRAYENBÜHL, H. P., LÜTHY, E. & HEGGLIN, R. (1964). Cardiovascular effects of catecholamines in dogs before and after β-adrenergic blockade. Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak., 246, 297-308.
31. LEVY, B. & TOZZI, S. (1963). The adrenergic receptive mechanism of the rat uterus. J. Pharmacol. exp. Ther., 142, 178-184.
32. LOWE, R. D. & ROBINSON, B. F. (1964). Effect of differential adrenergic blockade on response of forearm blood flow to infused catecholamines. Clin. Sci., 26, 81-87.
33. LUM, B. K. B. & KERMANI, M. H. (1963). Selective loss of response to alpha adrenergic agents following cold storage of the rabbit jejunum. Fed. Proc., 22, 449.
34. MCEWEN, L. M. (1956). The effect on the isolated rabbit heart of vagal stimulation and its modification by cocaine, hexamethonium and ouabain. J. Physiol. (Lond.), 131, 678-689.
35. MEESTER, W. D., HARDMAN, H. F. & BARBORIAK, J. J. (1963). Quantitative evaluation of nethalide (NET), dichloroisoproterenol (DCI) and N-isopropylmethoxamine (IPM) as beta-receptor blocking agents in the isolated rabbit heart. Pharmacologist, 5, 249.
36. MURRAY, W. J., MCKNIGHT, R. L. & DAVIS, D. A. (1963). Antagonism of hydrocarbon anaesthetic-epinephrine arrhythmias in dogs by nethalide, a dichloroisoproterenol analogue. Proc. Soc. exp. Bio., (N.Y.), 113, 439-441.
37. NAGASAKA, M., SCHAEPDRYVER, A. F. DE & HEYMANS, C. (1964). The anti-adrenergic property of nethalide on the isolated guinea-pig lung. Arch. int. Pharmacodyn., 149, 232-236.
38. ORLANS F. B. H., FINGER, K. F. & BRODIE, B. B. (1960). Pharmacological consequences of the selective release of peripheral norepinephrine by syrosingopine (SU 3118). J. Pharmacol. exp. Ther., 128, 131-139.
39. PAGET, G. E. (1963). Carcinogenic action of pronethalol. Brit. med. J., ii, 1266-1267.
40. PAYNE, J. P. & SENFIELD, R. M. (1964). Pronethalol in treatment of ventricular arrhythmias. Brit. med. J., i, 603-604.
41. SCHILD, H. O. (1947). A new scale for the measurement of drug antagonism. Brit. J. Pharmacol., 2, 189-206.
42. SCHRÖDER, G. & WERKÖ, L. (1964). Nethalide, a beta adrenergic blocking agent. Clin. Pharmacol. Ther., 5, 159-173.
43. SOMANI, P., HARDMAN, H. F. & LUM, B. K. B. (1963). Antagonism of cardiac arrhythmias by nethalide. Pharmacologist, 5, 260.
44. STOCK, J. P. P. & DALE, N. (1963). Beta-adrenergic receptor blockade in cardiac arrhythmias. Brit. med. J., ii, 1230-1233.
45. SUBBU, V. S. V., FLACKE, W. & SEIFEN, E. (1964). Adrenergic and β-blocking action of nethalide. Pharmacologist, 6, 165.
46. VAUGHAN WILLIAMS, E. M. & SEKIYA, A. (1963). Prevention of arrhythmias due to cardiac glyccsides by block of sympathetic β-receptors. Lancet, i, 420-421.